Status:

UNKNOWN

Effects of a High EPA Multinutrient Supplement on Negative Affect in Young Adults.

Lead Sponsor:

University of Roehampton

Conditions:

Anxiety

Depression

Eligibility:

All Genders

18-29 years

Phase:

NA

Brief Summary

This is a 12-week-long, randomised, double-blind, placebo-controlled trial exploring the efficacy of a high-EPA multinutrient supplement in the management of sub-clinical anxiety and depression. The i...

Detailed Description

First-line treatment for anxiety disorders comprises Cognitive Behavioural Therapy, which is ineffective in a considerable minority of individuals, and pharmacological treatments, which often confer s...

Eligibility Criteria

Inclusion

  • Age 18-29 years
  • GAD-7 Score ≥ 5
  • PHQ-8 Score ≥ 4
  • English language fluency.
  • Overall good health.

Exclusion

  • Self reported BMI ≥ 30 kg/m\^2.
  • Current tobacco smoker.
  • Diagnosis of anxiety, depression/major depressive disorder episode, psychosis, schizophrenia, bipolar disorder, eating disorders, haemophilia, or life-threatening disease during the preceding six months from the beginning of the trial.
  • Use of antidepressant drugs during the preceding six months from the beginning of the trial.
  • Participation to psychological and/or behavioural interventions during the preceding six months from the beginning of the trial.
  • Inability to ingest pills.
  • Pregnancy.
  • Breastfeeding.
  • Known allergy or intolerance to LCn-3 PUFAs, seafood and any of the constituents of the supplement under investigation.
  • High intake (more than twice per week) of oily fish (e.g. herring, pilchards, salmon, swordfish, sardines, sprats, trout or mackerel).
  • Use of fish oil supplements during the preceding six months from the beginning of the trial.
  • Inability to participate in the study for 12 consecutive weeks.

Key Trial Info

Start Date :

April 19 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

94 Patients enrolled

Trial Details

Trial ID

NCT04844034

Start Date

April 19 2022

End Date

December 1 2023

Last Update

June 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Roehampton

London, United Kingdom, SW15 4JD